Shield Therapeutics plc (SHIEF)
OTCMKTS
· Delayed Price · Currency is USD
0.0340
-0.0005 (-1.45%)
At close: Jan 31, 2025
Shield Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 6.52 | 13.95 | 3.4 | 12.12 | 2.94 | Upgrade
|
| Cash & Short-Term Investments | 6.52 | 13.95 | 3.4 | 12.12 | 2.94 | Upgrade
|
| Cash Growth | -53.23% | 309.99% | -71.92% | 312.14% | -29.00% | Upgrade
|
| Accounts Receivable | 24.97 | 9.99 | 3.39 | 0.82 | 0.22 | Upgrade
|
| Other Receivables | 0.29 | 1.23 | 1.13 | 0.96 | 0.44 | Upgrade
|
| Receivables | 25.25 | 11.21 | 4.52 | 1.77 | 0.66 | Upgrade
|
| Inventory | 5.66 | 3.2 | 1.76 | 1.64 | 1.38 | Upgrade
|
| Prepaid Expenses | - | 2.9 | 2.5 | 1.73 | 0.26 | Upgrade
|
| Restricted Cash | 0.5 | - | - | - | - | Upgrade
|
| Total Current Assets | 37.94 | 31.26 | 12.17 | 17.26 | 5.23 | Upgrade
|
| Property, Plant & Equipment | 0.37 | 0.67 | 0.24 | 0.3 | 0.03 | Upgrade
|
| Other Intangible Assets | 18.17 | 1.18 | 1.23 | 17.32 | 18.83 | Upgrade
|
| Long-Term Deferred Charges | - | 15.68 | 12.98 | 9.53 | 8.43 | Upgrade
|
| Other Long-Term Assets | 1 | - | - | - | - | Upgrade
|
| Total Assets | 57.48 | 48.8 | 26.62 | 44.41 | 32.53 | Upgrade
|
| Accounts Payable | 23.19 | 4.05 | 1.74 | 1.31 | 0.4 | Upgrade
|
| Accrued Expenses | - | 8.67 | 9.71 | 2.14 | 1.08 | Upgrade
|
| Current Portion of Leases | 0.2 | 0.21 | 0.11 | 0.16 | 0.03 | Upgrade
|
| Current Income Taxes Payable | - | 0.1 | 0.27 | 0.05 | 0.67 | Upgrade
|
| Other Current Liabilities | 9.24 | 0.7 | 1.01 | 0.06 | 0.08 | Upgrade
|
| Total Current Liabilities | 32.62 | 13.74 | 12.83 | 3.72 | 2.25 | Upgrade
|
| Long-Term Debt | 26.17 | 19.84 | 6.68 | - | - | Upgrade
|
| Long-Term Leases | - | 0.2 | - | - | - | Upgrade
|
| Other Long-Term Liabilities | - | - | 0.56 | - | - | Upgrade
|
| Total Liabilities | 58.8 | 33.77 | 20.07 | 3.72 | 2.25 | Upgrade
|
| Common Stock | 19.91 | 15.01 | 5.37 | 3.24 | 1.76 | Upgrade
|
| Additional Paid-In Capital | 203.19 | 198.76 | 169.48 | 114.58 | 88.35 | Upgrade
|
| Retained Earnings | -259.85 | -233.53 | -201.11 | -106.94 | -88.25 | Upgrade
|
| Comprehensive Income & Other | 35.43 | 34.79 | 32.8 | 29.81 | 28.41 | Upgrade
|
| Total Common Equity | -1.32 | 15.03 | 6.54 | 40.69 | 30.28 | Upgrade
|
| Shareholders' Equity | -1.32 | 15.03 | 6.54 | 40.69 | 30.28 | Upgrade
|
| Total Liabilities & Equity | 57.48 | 48.8 | 26.62 | 44.41 | 32.53 | Upgrade
|
| Total Debt | 26.37 | 20.25 | 6.79 | 0.16 | 0.03 | Upgrade
|
| Net Cash (Debt) | -19.85 | -6.3 | -3.39 | 11.96 | 2.91 | Upgrade
|
| Net Cash Growth | - | - | - | 310.75% | -29.34% | Upgrade
|
| Net Cash Per Share | -0.02 | -0.01 | -0.01 | 0.06 | 0.02 | Upgrade
|
| Filing Date Shares Outstanding | 1,030 | 782.06 | 259.39 | 215.89 | 117.62 | Upgrade
|
| Total Common Shares Outstanding | 1,030 | 782.06 | 259.39 | 215.89 | 117.62 | Upgrade
|
| Working Capital | 5.32 | 17.53 | -0.66 | 13.54 | 2.98 | Upgrade
|
| Book Value Per Share | -0.00 | 0.02 | 0.03 | 0.19 | 0.26 | Upgrade
|
| Tangible Book Value | -19.49 | 13.85 | 5.31 | 23.37 | 11.44 | Upgrade
|
| Tangible Book Value Per Share | -0.02 | 0.02 | 0.02 | 0.11 | 0.10 | Upgrade
|
| Machinery | - | 0.48 | 0.24 | 0.2 | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.